{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:09:29Z","timestamp":1773090569490,"version":"3.50.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This article reviews the evidence for drug-nutrient (DN) interactions associated with the chronic use of commonly prescribed psychiatric medications and suggests management strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Nutrient deficiencies due to DN interactions pose a risk for poorer patient outcomes. However, DN interaction studies and guidelines on preventing and managing DN abnormalities are lacking, with limited information for healthcare providers and patients to use as a resource. DN interactions can be caused by chronic use of psychiatric medications. Carbamazepine (CBZ), valproic acid (VPA), tricyclic antidepressants (TCAs), antipsychotics, and lithium can cause various vitamin B deficiencies. Calcium and\/or vitamin D levels can be decreased by CBZ, VPA, antidepressants (ie, TCAs and selective serotonin reuptake inhibitors), and antipsychotics. VPA and clozapine can cause selenium deficiency. VPA may also lower carnitine and zinc levels, while VPA and CBZ can decrease vitamin E levels. Lastly, coenzyme Q10 levels can be reduced by TCA use. Strategies for the detection and treatment of these deficiencies are provided in the article.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although widespread supplementation is not recommended, identifying at-risk individuals taking psychiatric medications for evaluation and, if needed, treatment can improve their nutrient status. The summary evidence provided can assist pharmacists in guiding recommendations for patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf280","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:06:48Z","timestamp":1761916008000},"page":"254-265","source":"Crossref","is-referenced-by-count":0,"title":["Identification and management of psychiatric medication\u2013induced nutrient depletion"],"prefix":"10.1093","volume":"83","author":[{"given":"Mollie A","family":"Cupp","sequence":"first","affiliation":[{"name":"University of Missouri\u2013Kansas City School of Pharmacy , Kansas City, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh Anne","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Pharmacy Practice and Administration, University of Missouri\u2013Kansas City School of Pharmacy , Kansas City, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"1","key":"2026030907325626100_zxaf280-B1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics10010036","article-title":"Evidence of drug-nutrient interactions with chronic use of commonly prescribed medications: an update","volume":"10","author":"Mohn","year":"2018","journal-title":"Pharmaceutics"},{"key":"2026030907325626100_zxaf280-B2"},{"key":"2026030907325626100_zxaf280-B3"},{"issue":"4","key":"2026030907325626100_zxaf280-B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/0148607113488799","article-title":"Chan LN. Drug-nutrient interactions","volume":"37","year":"2013","journal-title":"J Parenter Enter Nutr"},{"key":"2026030907325626100_zxaf280-B5","author":"Neustadt"},{"issue":"2","key":"2026030907325626100_zxaf280-B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7812\/TPP\/21.204","article-title":"B vitamins: functions and uses in medicine","volume":"26","author":"Hanna","year":"2022","journal-title":"Perm J"},{"issue":"3","key":"2026030907325626100_zxaf280-B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.yebeh.2012.04.132","article-title":"B-vitamin deficiency in patients treated with antiepileptic drugs","volume":"24","author":"Mintzer","year":"2012","journal-title":"Epilepsy Behav"},{"key":"2026030907325626100_zxaf280-B8","author":"National Institutes of Health"},{"key":"2026030907325626100_zxaf280-B9","author":"Rollins"},{"issue":"4","key":"2026030907325626100_zxaf280-B10","first-page":"317","article-title":"Effect of long-term treatment with antiepileptic drugs on the vitamin status","volume":"5","author":"Krause","year":"1988","journal-title":"Drug Nutr Interact"},{"key":"2026030907325626100_zxaf280-B11","author":"National Institutes of Health"},{"key":"2026030907325626100_zxaf280-B12","author":"National Institutes of Health. Biotin fact sheet for health professionals"},{"issue":"2","key":"2026030907325626100_zxaf280-B13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/s0006-3223(97)00544-1","article-title":"Vitamin B12 and folate levels and lithium administration in patients with affective disorders","volume":"45","author":"Cervantes","year":"1999","journal-title":"Biol Psychiatry"},{"key":"2026030907325626100_zxaf280-B14","author":"National Institutes of Health"},{"issue":"3","key":"2026030907325626100_zxaf280-B15","doi-asserted-by":"publisher","first-page":"CD004655","DOI":"10.1002\/14651858.CD004655.pub3","article-title":"Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency","volume":"3","author":"Wang","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2026030907325626100_zxaf280-B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-nutr-061121-084407","article-title":"Causes and clinical sequelae of riboflavin deficiency","volume":"43","author":"McNulty","year":"2023","journal-title":"Annu Rev Nutr"},{"key":"2026030907325626100_zxaf280-B17","author":"National Institutes of Health"},{"key":"2026030907325626100_zxaf280-B18","author":"Drug-induced nutrient deficiencies"},{"key":"2026030907325626100_zxaf280-B19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.seizure.2019.10.017","article-title":"Effects of valproic acid on bone mineral density and bone metabolism: a meta-analysis","volume":"73","author":"Fan","year":"2019","journal-title":"Seizure"},{"key":"2026030907325626100_zxaf280-B20","author":"National Institutes of Health"},{"key":"2026030907325626100_zxaf280-B21","author":"National Institutes of Health"},{"issue":"3","key":"2026030907325626100_zxaf280-B22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bone.2010.06.006","article-title":"Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures","volume":"47","author":"Verdel","year":"2010","journal-title":"Bone"},{"issue":"3","key":"2026030907325626100_zxaf280-B23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"issue":"5","key":"2026030907325626100_zxaf280-B24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Eom","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026030907325626100_zxaf280-B25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1759720X14546350","article-title":"Medication-induced osteoporosis: screening and treatment strategies","volume":"6","author":"Panday","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026030907325626100_zxaf280-B26","doi-asserted-by":"publisher","first-page":"12959","DOI":"10.1016\/j.psychres.2020.112959","article-title":"Vitamin D deficiency and schizophrenia in adults: a systematic review and meta-analysis of observational studies","volume-title":"Psychiatry Res","author":"Zhu","year":"2020"},{"issue":"10","key":"2026030907325626100_zxaf280-B27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/jcph.1625","article-title":"Effects of atypical antipsychotics on neuroactive vitamins in patients with schizophrenia","volume":"60","author":"Yuan","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"2026030907325626100_zxaf280-B28","doi-asserted-by":"publisher","first-page":"874705","DOI":"10.3389\/fpsyt.2022.874705","article-title":"Risperidone induced hyperprolactinemia: from basic to clinical studies","volume":"13","author":"Stojkovic","year":"2022","journal-title":"Front Psychiatry"},{"key":"2026030907325626100_zxaf280-B29","author":"National Cancer Institute"},{"issue":"6","key":"2026030907325626100_zxaf280-B30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/ajhp\/56.6.519","volume":"56","author":"Pepping J. Coenzyme Q10","year":"1999","journal-title":"Am J Health-Syst Pharm"},{"issue":"6","key":"2026030907325626100_zxaf280-B31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","article-title":"Biochemical functions of coenzyme Q10","volume":"20","author":"Crane","year":"2001","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"2026030907325626100_zxaf280-B32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jpsychires.2011.11.002","article-title":"Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients","volume":"46","author":"Moreno-Fern\u00e1ndez","year":"2012","journal-title":"J Psychiatr Res"},{"key":"2026030907325626100_zxaf280-B33","volume-title":"StatPearls","author":"Sood","year":"2024"},{"issue":"1","key":"2026030907325626100_zxaf280-B34","first-page":"100","article-title":"Coenzyme Q10: a review of clinical use and efficacy","volume":"1","author":"Elgar","year":"2021","journal-title":"Nutr Med J"},{"issue":"2","key":"2026030907325626100_zxaf280-B35","doi-asserted-by":"publisher","first-page":"103555","DOI":"10.1016\/j.sjbs.2022.103555","article-title":"L-Carnitine: nutrition, pathology, and health benefits","volume":"30","author":"Alhasaniah","year":"2023","journal-title":"Saudi J Biol Sci"},{"issue":"5","key":"2026030907325626100_zxaf280-B36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity\u2014what is the evidence? Crit Care","volume":"9","author":"Lheureux","year":"2005"},{"key":"2026030907325626100_zxaf280-B37","author":"National Institutes of Health"},{"key":"2026030907325626100_zxaf280-B38","volume-title":"StatPearls","author":"Shreenath","year":"2024"},{"issue":"6","key":"2026030907325626100_zxaf280-B39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1528-1157.1995.tb02574.x","article-title":"Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy","volume":"36","author":"K\u00fcrek\u00e7i","year":"1995","journal-title":"Epilepsia"},{"key":"2026030907325626100_zxaf280-B40","author":"National Institutes of Health"},{"issue":"3","key":"2026030907325626100_zxaf280-B41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-2125.2003.01773.x","article-title":"Low blood selenium concentrations in schizophrenic patients on clozapine","volume":"55","author":"Vaddadi","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"2-3","key":"2026030907325626100_zxaf280-B42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jtemb.2012.04.025","article-title":"Involvement of neuroleptic drugs in selenium deficiency and sudden death of cardiac origin: study and human post-mortem examination","volume":"26","author":"Hamdan","year":"2012","journal-title":"J Trace Elem Med Biol"},{"key":"2026030907325626100_zxaf280-B43","author":"National Institutes of Health"},{"issue":"2","key":"2026030907325626100_zxaf280-B44","first-page":"175","article-title":"Plasma vitamin E (\u03b1 tocopherol) levels in normal children and in epileptic children with and without anticonvulsant drug therapy","volume":"37","author":"Ogunmekan","year":"1985","journal-title":"Trop Geogr Med"},{"issue":"2","key":"2026030907325626100_zxaf280-B45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000480925","article-title":"Vitamin E status in pediatric patients receiving antiepileptic drugs","volume":"14","author":"Kataoka","year":"1989","journal-title":"Dev Pharmacol Ther"},{"issue":"10","key":"2026030907325626100_zxaf280-B46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1212\/wnl.34.10.1393","article-title":"Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects","volume":"34","author":"Hurd","year":"1984","journal-title":"Neurology"},{"issue":"12","key":"2026030907325626100_zxaf280-B47","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1177\/0883073811409227","article-title":"The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity","volume":"26","author":"Castro-Gago","year":"2011","journal-title":"J Child Neurol"},{"issue":"6468","key":"2026030907325626100_zxaf280-B48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/bmj.290.6468.603-a","article-title":"Cutaneous manifestations of zinc deficiency during treatment with anticonvulsants","volume":"290","author":"Lewis-Jones","year":"1985","journal-title":"Br Med J Clin Res Ed"},{"key":"2026030907325626100_zxaf280-B49","author":"National Institutes of Health"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf280\/65135488\/zxaf280.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/6\/254\/65135488\/zxaf280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/6\/254\/65135488\/zxaf280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:33:04Z","timestamp":1773055984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/6\/254\/8313672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,3]]},"published-print":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf280","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2025,11,3]]}}}